DrugNews.net
Speak with a patient advocate.
Understand your options.
Case Evaluation

Pradaxa Internal Bleeding

The drug Pradaxa was released in October 2010 to treat patients with atrial fibrillation. This medication is an anti-coagulant (“blood thinner”) prescribed to prevent blood clots, stroke and pulmonary embolism. Recently, the drug has been linked to dangerous side effects such as internal bleeding.

Authored by Chris Schroeder

Pradaxa is different from Coumadin and warfarin as patients are not required to undergo regular blood tests. Because of this convenience, Pradaxa quickly became one of the most -prescribed blood thinners in the world.

pradaxa gastrointestinal internal bleedingHowever, medical experts have linked the drug to serious health risks. Cases of Pradaxa internal bleeding and heart attacks have been reported by thousands of people. And, while Pradaxa is still on the market, a federal judge has ruled that those affected can proceed with lawsuits.

Reports of problems with Pradaxa were reported immediately after the drug’s release. Within six months, the FDA received over 500 reports of Pradaxa internal bleeding or death among patients, whereas such reports are a rarity with the older drugs, Coumadin and Warfarin.

While all blood thinner medications (including Coumadin and Warfarin) have a risk of causing internal bleeding, they can be effectively treated with “reversal agents.” There are no reversal agents for Pradaxa.

The maker of Pradaxa faces liability because they did not warn patients of this risk.

If you or someone you love suffered an injury or death after taking Pradaxa, speak with a lawyer about your legal options. You may be entitled to substantial compensation for your loss. It is important to act quickly, however, as there is limited time to file a claim.

Internal Bleeding Risk While on Pradaxa

The top public health and medical organizations have issued warnings about Pradaxa internal bleeding. Last year, the Institute for Safe Medication Practices ranked Pradaxa highest among all drugs for side effects and deaths in 2011.

The Journal for The American Medical Association also warned that the FDA may have rushed approval of Pradaxa, as the new FDA Expedited Drug Development Pathway may have overlooked key dangers, such as internal bleeding.

However, experts still have differing opinions on the safety of Pradaxa. While the FDA recently updated its Pradaxa information to say it has similar risks to warfarin or Coumadin, the American College of Cardiology has cautioned that its use can dramatically raise the risk of bleeding complications compared to both.

Also, a study from the University of Illinois at Chicago suggested that Pradaxa bleeding risks may be higher than the FDA expected. In the latest report, researchers from Denmark discovered that patients who switch from other blood thinners to Pradaxa could face higher risks of internal bleeding.

Lawyers are helping victims of Pradaxa internal bleeding file lawsuits against the drug’s manufacturer. Since hundreds or thousands of claims are expected, this has prompted consolidation into a special federal court in Illinois.

A Pradaxa lawyer can advise you on your legal options, available compensation, and statute of limitations on these cases (the time limit on taking action).

When choosing a lawyer, make sure they are qualified for this type of complex lawsuit and have the experience and resources to fight large drug companies.

The DrugNews Center only recommends law firms that specialize in mass defective drug cases and have handled Pradaxa lawsuits.

For more information on Pradaxa -- the side effects, warnings and legal action – contact us today. A lawyer is available 24 hours a day to provide help.

 

Last Modified: Monday, March 10, 2014